Absolute risk score for stroke, myocardial infarction, and all cardiovascular disease: Japan Arteriosclerosis Longitudinal Study

被引:0
作者
Akiko Harada
Hirotsugu Ueshima
Yuki Kinoshita
Katsuyuki Miura
Takayoshi Ohkubo
Kei Asayama
Yasuo Ohashi
机构
[1] Chuo University,Department of Integrated Science and Engineering for Sustainable Society, Faculty of Science and Engineering
[2] Shiga University of Medical Science,Center for Epidemiologic Research in Asia
[3] Shiga University of Medical Science,Department of Public Health
[4] Teikyo University School of Medicine,Department of Hygiene and Public Health
[5] Tohoku Institute for Management of Blood Pressure,undefined
来源
Hypertension Research | 2019年 / 42卷
关键词
Cardiovascular disease; Myocardial infarction; Risk score; Risk prediction model; Stroke;
D O I
暂无
中图分类号
学科分类号
摘要
To develop a risk chart or score that is based on recent data and applicable to the Japanese people, we need a large cohort study representative of the Japanese people without a need for long-term follow-up. The purpose of the present study was to develop a risk scoring system to estimate the 5- and 10-year absolute and cumulative incidence risk of stroke and acute myocardial infarction (AMI), composite outcome of stroke and AMI, and death from all cardiovascular disease (CVD). The cumulative incidence risk ratios were calculated using a multiple Poisson regression model and data from the Japan Arteriosclerosis Longitudinal Study, which included 67,969 men and women aged 40–89 years. An absolute risk scoring system for 5- and 10-year risk was developed. For blood pressure categories, the risk ratios for all outcomes increased from normal blood pressure (systolic blood pressure (SBP) 120–129 mmHg and diastolic blood pressure (DBP) 80–89 mmHg) to grade III hypertension (SBP ≥ 180 and/or DBP ≥ 110) based on the 2014 Guidelines for the Management of Hypertension compared to the reference optimal blood pressure (SBP < 120 and DBP < 80). Grade II (SBP 160–179 and/or DBP 100–109) and III hypertension treated with medication showed a lower risk compared to counterparts without medication. Other risk factors showed reasonable figures. The total of scores for each risk factor indicated the estimated absolute risk for stroke and AMI, the composite outcome of stroke and AMI, and all CVD. This scoring system may contribute to patient education and to the development of strategies for reducing CVD in the population.
引用
收藏
页码:567 / 579
页数:12
相关论文
共 174 条
[1]  
Arima H(2006)Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population Circ J 70 1249-55
[2]  
Yonemoto K(2009)Development and validation of a cardiovascular risk prediction model for Japanese: the Hisayama study Hypertens Res 32 1119-22
[3]  
Doi Y(2009)Risk charts illustrating the 10-year risk of myocardial infarction among residents of Japanese Rural Communities: the JMS Cohort Study J Epidemiol 19 94-100
[4]  
Ninomiya T(2009)Risk charts illustrating the 10-year risk of stroke among residents of Japanese Rural Communities: the JMS Cohort Study J Epidemiol 19 101-6
[5]  
Hata J(2010)Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events—the JALS-ECC Circ J 74 1346-56
[6]  
Tanizaki Y(2013)Development of a point-based prediction model for the incidence of total stroke: Japan public health center study Stroke 44 1295-302
[7]  
Matsumoto M(2014)Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study J Atheroscler Thromb 21 784-98
[8]  
Ishikawa S(2016)Development of a risk equation for the incidence of coronary artery disease and ischemic stroke for middle-aged Japanese—Japan Public Health Center-Based Prospective Study Circ J 80 1386-95
[9]  
Kayaba K(2012). Problems of the identification cause of death using Vital statistics in large cohort study in Japan (in Japanese) J Health Welf Stat 59 1-8
[10]  
Gotoh T(2003)Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network J Atheroscler Thromb 10 145-53